Table 1.
Characteristics | Controls | All ILD* | CTD-related ILD | Idiopathic ILD | p-value (controls vs all ILD) | |
---|---|---|---|---|---|---|
n patients | 13 | 30 | 15 | 14 | ||
Female sex | 62 | 47 | 67 | 29 | 0.37 | |
Age, mean years (SD) | 67.4 (13.7) | 50.0 (11.2) | 49.1 (10.7) | 51.0 (12.6) | <0.001 | |
Smoking behaviour | Never | 10 | 44 | 50 | 36 | 0.16 |
Previous | 70 | 48 | 50 | 46 | ||
Current | 20 | 8 | 0 | 18 | ||
FVC, % of predicted | 101 (90–105) | 84 (67–88) | 85 (69–89) | 83 (64–85) | <0.001 | |
n biopsies | 13 | 47 | 26 | 19 | ||
MDA, μmol/g lung tissue | 91 (87–101) | 101 (91–131) | 105 (90–133) | 101 (96–117) | 0.044 | |
COX/SDH-ratio | 0.12 (0.11–0.18) | 0.10 (0.04–0.13) | 0.10 (0.04–0.13) | 0.10 (0.04–0.12) | <0.001 | |
mtDNA, copies/pulmonary cell | 315 (267–471) | 419 (323–527) | 367 (301–484) | 434 (365–542) | 0.088 | |
COX2/COX4-ratio | 2.18 (2.10–2.43) | 0.64 (0.51–0.89) | 0.62 (0.51–0.89) | 0.72 (0.53–0.89) | <0.001 | |
common deletion, % of mtDNA molecules | 0 (0–13) | 17 (0–32) | 21 (0–36) | 15 (0–29) | <0.001 |
Presented are either percent or median (interquartile range) if not otherwise specified.
COX2/COX4, cytochrome c-oxidase subunit 2 protein normalized for cytochrome c-oxidase subunit 4 protein; COX/SDH-ratio, cytochrome c-oxidase/ succinate dehydrogenase activity ratio; CTD, connective tissue disease; ILD, interstitial lung disease; MDA, malondialdehyde; mtDNA, mitochondrial DNA; FVC, forced vital capacity; SD, standard deviation.
*In one patient it is unknown if the patient suffered from a CTD-related ILD or an idiopathic IDL.